Alvin Shih - SEC Form 4 Insider Trading Activity
Summary
Updated Aug 3, 2026
Alvin Shih has filed 1 SEC Form 4 filing across 1 company in the last 90 days - buying. Lifetime open-market purchases: $158K.
Profile
Alvin Shih holds the role of Director at ZEVRA THERAPEUTICS, INC. (ZVRA). Shih has reported 2 insider filings with the SEC since 2025. The most recent filing was in June 2026.
| Role | Director |
|---|---|
| Notability | 26/100 |
Board memberships
- ZEVRA THERAPEUTICS, INC.
Reported roles
- Director
Trading Pattern
InsiderAlpha's records for Alvin Shih go back to 2025: 2 primary Form 4 filings, an average of 1.0 per year. The typical open-market purchase is $158K (1 buy totaling $158K). The largest single buy on record is $158K of ZVRA in 2025. No transaction on record carries a Rule 10b5-1 flag - the filings look discretionary rather than pre-scheduled, which makes their timing more informative as a signal.
Career & Filing History
Every role Alvin Shih has reported on a Form 4, reconstructed from the filings themselves - reporting insiders must state their relationship to the issuer (officer title, director seat, or 10% ownership) on every filing.
- Director at ZEVRA THERAPEUTICS, INC. (ZVRA) - 2 filings, 2025 to 2026
Recent Transactions
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2025-09-15 | ZVRA | ZEVRA THERAPEUTICS, INC. | P - Open-market purchase | 20.0K | $7.89 | $158K |
Companies - Last 90 Days
- ZEVRA THERAPEUTICS, INC. (ZVRA) - 1 filing, last 2026-06-18
Other Insiders Active in the Same Stocks
Insiders who reported open-market trades at the companies Alvin Shih has recently filed at. Multiple unrelated insiders buying the same stock within a short window - cluster buying - has historically been one of the strongest Form 4 signals.
- Neil F. McFarlane - $1.19M of ZVRA open-market activity in the last 12 months
- Rahsaan Thompson - $495K of ZVRA open-market activity in the last 12 months
- Joshua Schafer - $126K of ZVRA open-market activity in the last 12 months
- John B. Bode - $46K of ZVRA open-market activity in the last 12 months
- Timothy J. Sangiovanni - $43K of ZVRA open-market activity in the last 12 months
- Adrian W. Quartel - $40K of ZVRA open-market activity in the last 12 months
More Notable Insiders
Other corporate insiders with significant SEC Form 4 track records on InsiderAlpha:
- Amwal Investments LLC
- Apollo Principal Holdings B GP, LLC
- Apollo Principal Holdings B, L.P.
- ARCH Venture Partners XII, LLC
- ARCH Venture Partners XIII, LLC
- Audax Private Credit Business, LP
- Milton C. Ault III
- BAIN CAPITAL INVESTORS LLC
Frequently Asked Questions
Who is Alvin Shih?
Alvin Shih holds the role of Director at ZEVRA THERAPEUTICS, INC. (ZVRA). Shih has reported 2 insider filings with the SEC since 2025. The most recent filing was in June 2026.…
How many SEC Form 4 filings has Alvin Shih submitted recently?
1 primary Form 4 filing in the last 90 days, covering 1 company.
Has Alvin Shih been buying or selling stock?
Recorded transactions: 1 open-market purchase ($158K) and 0 open-market sales across all tracked filings.
Where can I see all of Alvin Shih's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Learn More
Open the live Alvin Shih profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.